About clesrovimab
Long-acting monoclonal antibody against RSV
Used for
- Prevents serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants.
Usual adult dose
Not indicated for adults.
Usual dose in children
One intramuscular dose: 105 mg for infants weighing under 5 kg; 210 mg for infants weighing 5 kg or more.
Common side effects
- Injection-site reactions
- Rash
Important warnings
- Not for treating active RSV infection.
- Serious allergic reactions can occur.
- Use caution with bleeding disorders or low platelet counts.
Pregnancy
Not applicable; intended for infants.
Breastfeeding
Not applicable; intended for infants.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.